Multiplex immunoassay platform for detecting circulating cancer biomarkers in blood samples. Facilitates early diagnosis and treatment response monitoring in oncology patients.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GESIM Gesellschaft für Silizium-Mikrosysteme mbH
Germany · 3 relevant products
Qassay
United States · 1 relevant product
Atom Scientific Ltd
United Kingdom · 1 relevant product
Assure Tech. (Hangzhou) Co., Ltd.
China · 2 relevant products
Biopsense Oy
Finland · 1 relevant product
BEACON DIAGNOSTICS PVT. LTD.
India · 1 relevant product
Beijing Hotgen Biotech Co.,Ltd
China · 1 relevant product
Anbio Biotechnology Limited
Germany · 1 relevant product
Intelligenome
United States · 1 relevant product
PlexBio Co., Ltd.
Taiwan · 1 relevant product
60 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 93 closest product alternatives
GESIM Gesellschaft für Silizium-Mikrosysteme mbH · Germany
Multiplexed microarray assay for simultaneous detection of multiple tumor markers in clinical samples. Enables comprehensive cancer biomarker profiling in a single test.
Qassay · United States
Assay for detecting and quantifying cancer-related biomarkers. Supports early detection and monitoring through rapid point-of-care testing.
Atom Scientific Ltd · United Kingdom
Immunoassay systems for detecting cancer biomarkers in serum and plasma. Supports oncology screening and treatment monitoring applications.
Assure Tech. (Hangzhou) Co., Ltd. · China
Quantitative and qualitative assays for detection of tumor-associated markers using immunoassay technology. Supports oncology screening and monitoring applications in clinical laboratories.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
BEACON DIAGNOSTICS PVT. LTD. · India
Immunoassay kits for measurement of various tumor markers in serum samples. Supports cancer screening, diagnosis, and surveillance.
Beijing Hotgen Biotech Co.,Ltd · China
ELISA-based diagnostic kit for tumor marker detection and quantification. Supports cancer screening and monitoring in laboratory settings.
Anbio Biotechnology Limited · Germany
Comprehensive testing suite for oncology biomarkers including CEA, AFP, and CA markers. Supports cancer diagnosis, prognosis, and treatment monitoring.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
PlexBio Co., Ltd. · Taiwan
Comprehensive collection of molecular diagnostic assays for cancer detection and analysis. Includes advanced testing solutions for lung cancer and other oncological applications.
AVE Science & Technology Co.,Ltd. · China
Reagent system for measuring tumor-associated antigens in patient samples. Supports cancer screening and treatment monitoring.
Bio-Techne Diagnostics · United States
Precision oncology assay platform for detection of hematologic malignancies with multiplex capability. Provides automated analysis integrated into existing laboratory infrastructure.
81 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products